{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:19:38Z","timestamp":1761581978560,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00890","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T04:31:12Z","timestamp":1592973072000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Ibandronate Loading Dose on Rapid Pain Relief in Patients With Non-Small Cell Lung Cancer and Cancer Induced Bone Pain: The NVALT-9 Trial"],"prefix":"10.3389","volume":"10","author":[{"given":"Anita J. W. M.","family":"Brouns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizza E. L.","family":"Hendriks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"van der Noort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben E. E. M","family":"van de Borne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz M. N. H.","family":"Schramel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry J. M.","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonne","family":"Biesma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J. M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie C.","family":"Dingemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.lungcan.2014.01.006","article-title":"EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases?","volume":"84","author":"Hendriks","year":"2014","journal-title":"Lung Cancer"},{"key":"B2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2217\/fon-2018-0613","article-title":"Bone metastases and skeletal-related events: incidence and prognosis according to histological subtype of lung cancer","volume":"15","author":"Silva","year":"2019","journal-title":"Future Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.lungcan.2007.03.013","article-title":"Skeletal metastases in non-small cell lung cancer: a retrospective study","volume":"57","author":"Tsuya","year":"2007","journal-title":"Lung Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"18670","DOI":"10.1038\/srep18670","article-title":"Natural history of non-small-cell lung cancer with bone metastases","volume":"5","author":"Santini","year":"2015","journal-title":"Sci Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"iii124","DOI":"10.1093\/annonc\/mdu103","article-title":"Bone health in cancer patients: ESMO clinical practice guidelines","volume":"25","author":"Coleman","year":"2014","journal-title":"Ann Oncol"},{"key":"B6","unstructured":""},{"key":"B7","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/bcp.13801","article-title":"Mechanisms that drive bone pain across the lifespan","volume":"85","author":"Mantyh","year":"2019","journal-title":"Br J Clin Pharmacol."},{"volume-title":"The Diagnosis and Treatment of Lung Cancer (Update).","year":"2011","author":"White","key":"B8"},{"key":"B9","doi-asserted-by":"publisher","first-page":"807","DOI":"10.6004\/jnccn.2018.0062","volume":"16","author":"Ettinger","year":"2018","journal-title":"NCCN Guidelines Version 4.2018 Non-Small Cell Lung Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"iv192","DOI":"10.1093\/annonc\/mdy275","article-title":"Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Planchard","year":"2018","journal-title":"Ann Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jtho.2015.10.001","article-title":"Effect of bisphosphonates, denosumab, and radioisotopes on bone pain and quality of life in patients with non-small cell lung cancer and bone metastases: a systematic review","volume":"11","author":"Hendriks","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/sj.pcan.4500574","article-title":"Ibandronate in the treatment of prostate cancer associated painful osseous metastases","volume":"5","author":"Heidenreich","year":"2002","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1200\/JCO.2004.07.054","article-title":"Efficacy and safety of ibandronate in the treatment of opioid-resistant bone pain associated with metastatic bone disease: a pilot study","volume":"22","author":"Mancini","year":"2004","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pain.2004.07.011","article-title":"Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer","volume":"111","author":"Body","year":"2004","journal-title":"Pain"},{"key":"B15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jpainsymman.2014.05.021","article-title":"Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial","volume":"49","author":"Riley","year":"2015","journal-title":"J Pain Symptom Manage"},{"key":"B16","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S1470-2045(05)70317-X","article-title":"Controversies in pharmacotherapy of pain management","volume":"6","author":"Davis","year":"2005","journal-title":"Lancet Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ctrv.2018.04.014","article-title":"The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer","volume":"68","author":"Saad","year":"2018","journal-title":"Cancer Treat Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"CD003474","DOI":"10.1002\/14651858.CD003474.pub3","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"15","author":"Wong","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.orthres.2003.03.004","article-title":"Bone resorption activity of osteolytic metastatic lung and breast cancers","volume":"22","author":"Shih","year":"2004","journal-title":"J Orthop Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1007\/s00520-012-1563-z","article-title":"Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis","volume":"20","author":"Lopez-Olivo","year":"2012","journal-title":"Support Care Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/bmj.327.7408.195","article-title":"A systematic review of physicians' survival predictions in terminally ill cancer patients","volume":"327","author":"Glare","year":"2003","journal-title":"BMJ"},{"key":"B22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/pon.1727","article-title":"Patient and oncologist estimates of survival in advanced cancer patients","volume":"20","author":"Kao","year":"2011","journal-title":"Psychooncology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1200\/JOP.2014.001457","article-title":"Simple prognostic model for patients with advanced cancer based on performance status","volume":"10","author":"Jang","year":"2014","journal-title":"J Oncol Pract"},{"key":"B24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1017\/S1478951509990216","article-title":"Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients","volume":"7","author":"Grande","year":"2009","journal-title":"Palliat Support Care"},{"key":"B25","unstructured":"ScottNW\n            FayersPM\n            AaronsonNK\n            BottomleyA\n            de GraeffA\n            GroenvoldM\n          EORTC QLQ-C30 Reference Values2008"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11136-017-1745-8","article-title":"Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases","volume":"27","author":"Raman","year":"2018","journal-title":"Qual Life Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00890\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T04:31:15Z","timestamp":1592973075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00890\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":26,"alternative-id":["10.3389\/fonc.2020.00890"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00890","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2020,6,24]]},"article-number":"890"}}